GLB1 gene therapy (Pharma Gateway)

N/A

Report date: 2025/01/26 19:33:39

Base Information

Drug NameGLB1 gene therapy (Pharma Gateway)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionBeta-galactosidase stimulants
TargetsBeta-galactosidase
Therapy Area/IndicationsGangliosidosis, GM1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharma Gateway AB
China Registration ClassN/A

Develop Information

Active CompaniesPharma Gateway AB
Inactive CompaniesN/A
Active IndicationsGangliosidosis, GM1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A